Virus Capture Kits

Get more from your samples and get it faster.  Knowing a virus is present in a sample and not being able to detect it is frustrating. Use Nanotrap® Magnetic Virus Particles to concentrate viruses rapidly from complex biological matrices in order to have high quality input material for your downstream analytical methods.

   PRODUCT DESCRIPTION

  • Nanotrap® Magnetic Virus Particles capture and concentrate the following respiratory viruses: influenza A H1N1 (1), Influenza A H3N2 (1), influenza B (1), respiratory syncytial virus A2001/3-12 strain (1), coronavirus strain 229E (1), coronavirus strain OC43 (2), and SARS-CoV-2 (3)(4).

  • Methods developed for clinical swab samples, saliva, and wastewater. (3)(4)(5)(7)(8)

  • Reduce clinical sample processing time by 2- to 3-fold by eliminating commercial extraction kit. 

  • Enables an automated method for concentrating and processing virus from 24 wastewater samples in 40 minutes, reducing processing time by at least 20-fold, as compared to other methods. (8)

  • Enables pooled patient sample testing with methods developed for sample volumes up to 10 mL. (4)(6)

  • Eliminate false negatives. Nanotrap particles enabled the identification of SARS-CoV-2 RNA in 9 out of 32 diagnostic remnant samples that had previously tested negative for the virus. (4)

  • Increase assay sensitivity by capturing and concentrating low abundance viruses. Nanotrap particles improved the real-time RT-PCR signal in low viral load diagnostic remnant samples by an average of 3.1 Ct values. (4)

  • Successfully utilized in RT-PCR assays with FDA Emergency Used Authorization for COVID-19. (9)

  • Nanotrap® particles utilize affinity capture and enrichment to attract and bind low abundance viruses. Nanotrap® particles do not utilize antibodies or other biomolecules as affinity molecules.

Citations:

(1)  https://www.ceresnano.com/post/respiratory-pathogen-detection

(2)  https://www.ceresnano.com/post/app-note-capture-and-concentration-of-coronavirus-oc43

(3)  https://www.ceresnano.com/post/app-note-capture-and-concentration-of-sars-cov-2-from-viral-transport-medium

(4)  https://www.biorxiv.org/content/10.1101/2020.06.25.172510v2

(5) https://www.ceresnano.com/post/app-note-rapid-sars-cov-2-rna-extraction-from-saliva-samples

(6) https://www.ceresnano.com/post/app-note-rapid-sars-cov-2-rna-extraction-from-universal-transport-medium-pooled-sample-mimics

(7) https://www.ceresnano.com/post/app-note-rapid-sars-cov-2-viral-isolation-from-wastewater

(8) https://www.medrxiv.org/content/10.1101/2020.11.16.20232900v1

(9) https://www.fda.gov/media/136151/download

Incorporating the Nanotrap® technology into your workflow is simple. ​Reduce your sample real-time RT-PCR sample processing time by 2-3 fold by eliminating a commercial extraction kit altogether.

AVAILABLE PRODUCTS

Nanotrap® Magnetic Virus Particles

Nanotrap® Magnetic Virus Particles in solution

SKU#

44202

Nanotrap® Virus Capture Kit (10)

2 mL of Nanotrap® Lyophilized Magnetic Virus Particles (10 x 0.2 mL)

SKU#

44210

Nanotrap® Virus Capture Kit (50)

10 mL of Nanotrap® Lyophilized Magnetic Virus Particles (50 x 0.2 mL)

SKU#

44250

 
  • LinkedIn Classic
  • Twitter App Icon
  • Facebook Social Icon

9460 Innovation Drive, Manassas, VA, 20110, United States

800-615-0418 / info@ceresnano.com

© 2020 Ceres Nanosciences, Inc. All Rights Reserved